CBD 뉴트라슈티컬 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

CBD Nutraceuticals Market Growth & Trends:

The global CBD nutraceuticals market size is anticipated to reach USD 23.17 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 12.6% from 2025 to 2030. Introduction of the 2018 Farm Bill that legalized hemp cultivation and hemp-derived products in U.S., rising consumer preference for plant-based ingredients in dietary supplements, and awareness regarding the health benefits of cannabidiol are some of the factors powering the market growth. However, the easy availability of alternative products is obstructing market growth.

CBD tinctures segment dominated the global market and accounted for a revenue share of 41.9% in 2023. Increasing acceptance of cannabidiol for health and wellness purposes coupled with high bioavailability of tinctures when administered sublingually are the major factors responsible for this large market share. On the other hand, capsules and soft gels are anticipated to be the fastest-growing product type over the forecast period, as they are travel-friendly and convenient to carry in public places. However, many consumers dislike the raw taste and texture of cannabidiol and so they are switching towards capsules and softgels.

Based on the distribution channel, retail store segment dominated the market in 2023, as consumers prefer retail stores for buying dietary supplements due to attractive pricing. On the other hand, the online sales channel is expected to expand at the fastest CAGR over the forecast period owing to the rise in the preference for online shopping. Furthermore, the new entrants in the CBD nutraceuticals space, find online sales channel a much economical alternative than a retail storefront.

CBD Nutraceuticals Market Report Highlights:

• CBD tinctures segment dominated the global market and accounted for a revenue share of 41.9% in 2024. The ability of the product to provide effective solutions for health problems, such as assistance in treatments of chronic pain, depression, and substance use disorders, the capacity to alleviate specific cancer symptoms, and ease of availability, contribute to this segment's growth.
• The edibles and fortified foods segment accounted for the largest revenue share in 2024. The growth is attributed to advancements in formulations of CBD foods and growing awareness among consumers about its health benefits.
• Retail stores segment dominated the global market in 2024. Ease of accessibility, availability of multiple alternatives, and preference by key companies in order to accomplish enhanced brand visibility have contributed to the growth of retail store segment.
• North America CBD nutraceuticals market dominated the global industry with a revenue share of 54.5% in 2024. This market is primarily driven by rising consumer awareness, increased adoption of CBD in various applications, and positive regulatory scenarios in countries such as the U.S. and Canada.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. CBD Nutraceuticals Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. CBD Nutraceuticals Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. CBD Nutraceuticals Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. CBD Nutraceuticals Market: Product Movement Analysis, 2024 & 2030 (USD Million)
• 4.3. CBD Tinctures
  • 4.3.1. CBD Tinctures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Capsules & Softgels
  • 4.4.1. Capsules & Softgels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. CBD Gummies
  • 4.5.1. CBD Gummies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. CBD Nutraceuticals Market: Distribution Channel Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. CBD Nutraceuticals Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Million)
• 5.3. Retail Stores
  • 5.3.1. Retail Stores Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Online
  • 5.4.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Pharmacies
  • 5.5.1. Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. CBD Nutraceuticals Market: Regional Estimates & Trend Analysis

• 6.1. CBD Nutraceuticals Market Share, By Region, 2024 & 2030 (USD Million)
• 6.2. North America
  • 6.2.1. North America CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. U.S. CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Canada CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Mexico CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. UK CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Germany CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. Netherlands
    • 6.3.4.1. Netherlands CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Switzerland
    • 6.3.5.1. Switzerland CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Italy
    • 6.3.6.1. Italy CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. France
    • 6.3.7.1. France CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Poland
    • 6.3.8.1. Poland CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Czech Republic
    • 6.3.9.1. Czech Republic CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.10. Croatia
    • 6.3.10.1. Croatia CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. China
    • 6.4.2.1. China CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. India
    • 6.4.3.1. India CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Australia
    • 6.4.4.1. Australia CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. South Korea
    • 6.4.5.1. South Korea CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. Japan
    • 6.4.6.1. Japan CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. New Zealand
    • 6.4.7.1. New Zealand CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Brazil CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Argentina CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Chile
    • 6.5.4.1. Chile CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Colombia
    • 6.5.5.1. Colombia CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Uruguay
    • 6.5.6.1. Uruguay CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East and Africa
  • 6.6.1. Middle East and Africa CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. South Africa CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Israel
    • 6.6.3.1. Israel CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Charlotte's Web, Inc.
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/ Strategic Initiatives
  • 7.4.2. Elixinol
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/ Strategic Initiatives
  • 7.4.3. Medical Marijuana, Inc.
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/ Strategic Initiatives
  • 7.4.4. CV Sciences, Inc.
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/ Strategic Initiatives
  • 7.4.5. Irwin Naturals
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/ Strategic Initiatives
  • 7.4.6. Diamond CBD.
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/ Strategic Initiatives
  • 7.4.7. Foria Wellness (Eden Partners LLC)
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/ Strategic Initiatives
  • 7.4.8. Medterra CBD
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/ Strategic Initiatives
  • 7.4.9. Green Roads
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/ Strategic Initiatives
  • 7.4.10. Isodiol International Inc
    • 7.4.10.1. Participant's Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Recent Developments/ Strategic Initiatives